Insights On Regulatory Compliance

  1. Site Expansion Success Blueprint 3/31/2026

    Discover how a global pharmaceutical manufacturer unified six sites under one asset management strategy, improving compliance and scalability to help teams plan, prepare data, and expand confidently.

  2. Navigating Nitrosamine Impurities In Pharmaceutical Drug Development 3/3/2026

    Understanding formation mechanisms and potency categorization allows developers to mitigate risks early, ensuring regulatory compliance and patient safety without compromising product performance.

  3. Annex 1 In Practice: Turning CCS Into Cleanroom Design 9/24/2026

    Learn how embedding a contamination control strategy into early facility design mitigates risk, protects product quality, and ensures regulatory compliance.

  4. Achieve Pharma 4.0 With Next Generation Software-Defined Manufacturing 11/5/2025

    Explore how software-defined manufacturing is helping companies overcome legacy system challenges, improve OEE by up to 25%, and accelerate batch release cycles while maintaining compliance.

  5. This Is Where Quality Starts 3/20/2026

    Quality takes shape long before a workcell ships. Meet the people and processes that ensure consistent performance through every stage of development, and explore how to build reliability into each step.

  6. Viral Vector Technology Transfers: A Guide To Success 11/13/2025

    Strategic, well-aligned partnerships between sponsors and CDMOs are key to efficient, scalable viral vector technology transfer.

  7. How A Rigorous Approach Delivers Unparalleled Results 6/12/2025

    In critical environments where mistakes have serious consequences, a disciplined, methodical approach isn't just a preference—it's the only path to success and long-term operational excellence.

  8. Optimizing Antibody Variant Capture: Strategies To Combat Aggregation, Impurities, And Low Yields 2/26/2026

    Explore how process conditions affect bispecific antibody stability and impurity formation, as well as practical strategies to minimize aggregation and remove product‑related variants.

  9. Aiming For Success In Early mAb Process Development And Beyond 7/15/2025

    Developing a monoclonal antibody (mAb) requires strict quality compliance. Building on a strong foundation from the start with a quality by design (QbD) approach is key for success and minimizing variability.

  10. Alleviate Compliance Risks With Your EAM/CMMS 3/2/2026

    Discover how unified asset management enhances audit readiness by connecting maintenance, calibration, and quality insights, as well as how integrated workflows reduce compliance risk.